Publications:

RET in breast cancer: pathogenic implications and mechanisms of drug resistance.

Cancer Drug Resistance (Alhambra, Calif.)

Lo Nigro, Cristiana C; Rusmini, Marta M; Ceccherini, Isabella I

Publication Date: 2019

Variant appearance in text: rs12247456

PubMed Link: 35582269

Variant Present in the following documents:

• cdr-2-1136.pdf

View BVdb publication page

A multi-enhancer RET regulatory code is disrupted in Hirschsprung disease.

Genome Research

Chatterjee, Sumantra S; Karasaki, Kameko M KM; Fries, Lauren E LE; Kapoor, Ashish A; Chakravarti, Aravinda A

Publication Date: 2021-11-15

Variant appearance in text: rs12247456

PubMed Link: 34782358

Variant Present in the following documents:

• Main text
• 2199.pdf

View BVdb publication page

Genetic and epigenetic factors affect RET gene expression in breast cancer cell lines and influence survival in patients.

Oncotarget

Griseri, Paola P; Garrone, Ornella O; Lo Sardo, Alessandra A; Monteverde, Martino M; Rusmini, Marta M; Tonissi, Federica F; Merlano, Marco M; Bruzzi, Paolo P; Lo Nigro, Cristiana C; Ceccherini, Isabella I

Publication Date: 2016-05-03

Variant appearance in text: rs12247456

PubMed Link: 27034161

Variant Present in the following documents:

• Main text
• oncotarget-07-26465.pdf

View BVdb publication page